Variable bone mass recovery in hyperthyroid bone disease after radioiodine therapy in postmenopausal patients

Maturitas

Volumn 35, Issue 2, 2000, Pages 159-166

  Obermayer Pietsch, B ^a   Dobnig, H ^a   Warnkross H ^a   Dimai, H P ^a   Weber, K ^a   Berghold, A ^b   Leb, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bone mineral density; Hyperthyroid bone disease; Hyperthyroidism; Osteoporosis; Radioiodine therapy

Indexed keywords

OSTEOCALCIN; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; OSTEOPOROSIS; PATIENT SELECTION; POSTMENOPAUSE;

AGED; AGED, 80 AND OVER; BONE DENSITY; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0034729066     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00114-6     Document Type: Article

References (35)

1. Von Recklinghausen F. Die fibröse und deformierende Ostitis, die Osteomalacie und die osteoplastische Carcinose, in ihren gegenseitigen Beziehungen. Festschrift für Rudolf Virchow. 1891;1-89 Georg Reimer, Berlin.
2. Auwerx J., Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Q. J. Med. 232:1986;737-752.
3. Mosekilde L., Eriksen E.F., Charles P. Effects of thyroid hormones on bone mineral metabolism. Endocrinol. Metab. Clin. North Am. 19:1990;35-63.
4. Ross D.S. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid. 4(3):1994;319-326.
5. Eriksen E.F., Mosekilde L., Melsen F. Trabecular bone remodeling and bone balance in hyperthyroidism. Bone. 6:1985;421-428.
6. Jodár Gimeno E., Muños-Torres M., Escobar-Jiménez F. et al. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover. Calcif. Tissue Int. 61:1997;370-376.
7. Mosekilde L., Jastrup B., Melsen F. et al. Effect of propranolol treatment on bone mass, bone mineral content, bone remodeling, parathyroid function and vitamin D metabolism in hyperthyroidism. Eur. J. Clin. Invest. 14:1983;96-1023.
8. Langdahl B.L., Loft A.G., Moller N. et al. Skeletal responsiveness to thyroid hormone is not altered at menopause. Bone. 19(5):1996;557-564.
9. Campos-Pastor M.M., Muños-Torres M., Escobar Jiménez F. et al. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner. 21:1993;1-8.
10. DeMenis E., Da Rin G., Roiter I. et al. Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma. Horm. Res. 37:1992;217-220.
11. Földes J., Tarján G., Szathmari M. et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin. Endocrinol. 39:1993;521-527.
12. Grant D.J., McMurdo M.E., Mole P.A. et al. Is previous hyperthyroidism still a risk factor for osteoporosis in postmenopausal women? Clin. Endocrinol. Oxf. 43:1995;339-345.
13. Kanis J.A., McCloskey E.V. Risk factors in osteoporosis. Maturitas. 30(3):1998;229-233.
14. Lee M.S., Kim S.Y., Lee M.C. et al. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J. Clin. Endocrinol. Metab. 70:1990;766-770.
15. Lehmke J., Bogner D., Felsenberg D. et al. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism; a risk of early osteopaenia in postmenopausal women. Clin. Endocrinol. 36:1992;511-517.
16. Schoutens A., Laurent E., Markovicz E. et al. Serum triiodothyronine, bone turnover, and bone mass changes in euthyroid pre and postmenopausal women. Calcif. Tissue Int. 49:1991;95-100.
17. Wakasugi M., Wakao R., Tawata M. et al. Bone mineral density in patients with hyperthyroidism measured by dual X-ray absorptiometry. Clin. Endocrinol. 38:1993;283-286.
18. Bauer D.C., Nevitt M.C., Ettiner B. et al. Low thyrotropin levels are not associated with bone loss in older women: a prospective study. J. Clin. Endocrinol. Metab. 82(9):1997;2931-2936.
19. Faber J., Jensen I.W., Petersen L. et al. Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect of bone loss in postmenopausal women. Clin. Endocrinol. Oxf. 48(3):1998;285-290.
20. Fraser S.A., Anderson J.B., Smith D.A. et al. Osteoporosis and fractures following thyrotoxicosis. Lancet. 1:1971;981-983.
21. Toh S.H., Claunch B.C., Brown P.H. Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Intern. Med. 145:1985;883-886.
22. Kanis J.A., Melton L.J. III, Christiansen C. et al. The diagnosis of osteoporosis. J. Bone Miner. Res. 9:1994;1137-1141.
23. Franklyn J., Betteridge J., Holder R. et al. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin. Endocrinol. 41:1994;425-432.
24. Lunt M., Felsenberg D., Reeve J. et al. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS study. J. Bone Miner. Res. 12(11):1997;1883-1894.
25. Rosen C.J., Adler R.A. et al. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J. Clin. Endocrinol. Metab. 75:1992;1531-1534.
26. Bayley T.A., Harrison J.E., McNeill K.G. et al. Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J. Clin. Endocrinol. Metab. 50:1980;916-922.
27. Lakatos P., Földes J., Horvath C. et al. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J. Clin. Endocrinol. Metab. 82(1):1997;78-81.
28. Diamond T., Vine J., Smart R. et al. Thyrotoxic bone disease in women: a potentially reversible disorder. Ann. Intern. Med. 120:1994;8-11.
29. Garnero P., Vassy V., Bertholin A. et al. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab. 78:1994;955-959.
30. MacLeod J.M., McHardy K.C., Harvey R.D. et al. The early effects of radioiodine therapy for hyperthyroidism on biochemical indices of bone turnover. Clin. Endocrinol. Oxf. 38(1):1993;49-53.
31. Peerenboom H., Keck E., Kruskemper H.L., Strohmeyer G. The defect of intestinal calcium transport in hyperthyroidism and its response to therapy. J. Clin. Endocrinol. Metab. 59:1984;936-940.
32. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I. et al. Hypovitaminosis D in medical inpatients. New Engl. J. Med. 338(12):1998;777-783.
33. Gennari L., Becherini L., Masi L. et al. Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women. Calcif. Tissue Int. 61(6):1997;460-463.
34. Obermayer-Dietsch BM, Fruhauf GE, Chararas K et al. Association of the vitamin D receptor genotype 'BB' with low bone density in hyperthyroidism, J Bone Miner Res 2000, in press.
35. Netelenbos C. Osteoporosis: intervention options. Maturitas. 30(3):1998;235-239.